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http://dx.doabstractBACKGROUND: Tuberous sclerosis complex is a multisystem disorder that includes a range of tuberous scle-
rosiseassociated neuropsychiatric disorders (TAND). The lifetime prevalence rates of TANDare very high; yet surveys
suggest that themajorityof individualswith tuberous sclerosisnever receive appropriate assessmentor treatment for
TAND. To aid systematic enquiry, a TAND Checklist was developed. Here, we performed pilot validation of the TAND
Checklist. METHOD: Mixed methods were used across two stages. In stage 1, we gathered feedback on the Checklist
from tuberous sclerosis “expert professionals” and “expert parents and caregivers.” The aimwas to examine face and
content validity. Stage 2 involved the administration of the reﬁned TAND Checklist to 20 parents of individuals with
tuberous sclerosis concurrentlywith fourwidely used validated rating scales, to examine external validity and obtain
qualitative feedback on face-to-face administration of the TAND Checklist. RESULTS: Twenty professionals and 62
parents and caregivers from 28 countries participated in the pilot. The TAND Checklist demonstrated good face and
content validity with high overall mean and median scores. Qualitative analysis highlighted concerns about the
likely use of the TAND Checklist, suggesting that family members and individuals with tuberous sclerosis should
drive usage. Stage 2 results showed moderate-to-very good external validity across TAND domain and key sub-
domains. Internal consistency of domains and subdomains was acceptable to very good. Ninety-three percent of all
participants (93%) reported four or more lifetime TAND behavioral difﬁculties. CONCLUSION: The pilot validation
suggested that the TAND Checklist could provide a useful screening tool in clinical settings.
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i.org/10.1016/j.pediatrneurol.2014.10.006systems.1,2 The physical manifestations include benign tu-
mors in the heart, kidneys, lungs, skin, and brain. TSC is
caused by mutations in either of two genes, the TSC1 gene
(9q34)3,4 or the TSC2 gene (16p13.3).4,5 TSC has a birth
incidence estimated around one in 6000.6-8 Appropriate
management and coordination of medical specialist care
are crucial across the lifespan of individuals with TSC to
limit morbidity and mortality in this disease.9The neuropsychiatry of TSC
TSC is also associated with a vast range of neuropsychi-
atric disorders.10-13 At a behavioral level, difﬁculties include
restless and impulsive behavior, high rates of aggres-
sion,14-16,18 temper tantrums,15 and self-injury.15-18 At thes reserved.
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autism spectrum disorders (ASD, 40-50%)19 and attention
deﬁcit hyperactivity disorder (ADHD, 30-50%), are
commonly observed.10,12,20 High rates of depression and
anxiety disorder have also been documented.15,20-23 At the
intellectual level, approximately 50% of individuals with
TSC have normal intellectual abilities, and others have
varying degrees of intellectual disability (ID).13,24,25 At the
academic level, many school-aged children with TSC have
academic difﬁculties, for instance, in mathematics, reading,
writing, and spelling.13 At the neuropsychologic level a
range of neuropsychologic deﬁcits are also observed. These
include difﬁculties with executive, attentional, memory,
and language skills.12,13,26-30 At the psychosocial level, there
is growing evidence of the impact of TSC on, for instance,
self-esteem, family stress, and parental relationships.31
Each individual with TSC will exhibit their own unique
combination of strengths and weaknesses, and this proﬁle
may change over time. Taken together, the majority of in-
dividuals with TSC will have some neuropsychiatric prob-
lems in their lifetime, with lifetime prevalence rates in the
region of 90%.32
TSC-associated neuropsychiatric disorders (TAND)
In 2010, a survey of members of the Tuberous Sclerosis
Association in the United Kingdom indicated that only 18%
of individuals with TSC had ever received an assessment or
treatment for neuropsychiatric disorders (personal
communication P.J.d.V.). These results suggested a treat-
ment gap of around 70%. At the 2012 International TSC
Consensus Conference,9 the Neuropsychiatry panel
expressed concern about the enormous treatment gap and
about the confusion of terminology across different levels of
investigation of the biopsychosocial aspects of TSC. The
panel decided to coin the term TAND, TSC-Associated
Neuropsychiatric Disorders, as an umbrella term to refer
to all the levels of investigation listed previously and agreed
to generate a TAND Checklist as a potential screening
tool.9,32 The panel did not want to develop a “diagnostic”
tool, but rather a screening “Checklist” to guide health-care
teams in a systematic enquiry of the current behavioral,
psychiatric, intellectual, academic, neuropsychologic, and
psychosocial difﬁculties of the individual with TSC. Details
of the conceptualization of TAND and the TAND Checklist
are presented in de Vries et al.32
Checklists are aimed at reducing errors of omission and
are generally easy to administer and understand.33
Although numerous standardized tools existed for
screening and diagnosis of a range of neuropsychiatric
disorders, many of these tools have not been validated
across all ages and developmental levels, most are not
routinely available at clinics, and where they are used, tools
are typically copyrighted with a charge per use.
The TAND Checklist
One of the goals of the Neuropsychiatry Panel was
therefore to develop a simple TSC Checklist that would be
globally and freely available to all clinicians and families. The
TAND Checklist32 includes an item on basic developmental
milestones (Question 1), one on current level of functioning(Question 2), a behavioral item with 19 YES/NO questions
about behaviors of concern (Question 3), a psychiatric item
listing high frequency mental health diagnoses seen in TSC
(Question 4), and items on intellectual disability (Question
5), academic skills (Question 6), neuropsychologic skills
(Question 7), and psychosocial functioning (Question 8). The
TAND Checklist also includes a parent, caregiver or self-
rating of the impact of TAND (Question 9) and a similar item
where the health-care professional who completes the TAND
Checklist with the person provides an overall TAND impact
score (Question 12). Items 10 and 11 allow for prioritization
or addition of extra concerns.
As part of the development of the TAND Checklist, it was
important that it be deemed to have face validity (observed by
professionals and families as capturing the essential and
important aspects of concern), content validity (judged by
experts to cover the range of neuropsychiatric concerns of
relevance to TSC), and transferability (the ability of the tool to
be used across different settings by different people). Here,
we performed pilot validation of the TAND Checklist with the
aimof evaluating the face, content, and subsequent validity as
well as internal consistency and external validity of the tool.
Methods
The pilot study was conducted in two stages using mixed method-
ology. In Stage 1, quantitative and qualitative feedback was collected on
the draft TAND Checklist from two expert groups, a multidisciplinary
panel of international TSC experts (referred to as the “expert profes-
sional” group) and an international panel of user and caregiver repre-
sentatives (referred to as the “expert parent and caregiver” group).
Experts were provided with either an electronic copy or a paper version
of the TAND Checklist in English and an Expert Feedback Form in English.
The Expert Feedback Form consisted of ﬁve quantitative and open-ended
qualitative items to capture aspects of comprehensiveness, clarity, ease
of use, applicability, and subsequent validity. Stage 1 data were used to
examine internal consistency of the TAND Checklist.
In Stage 2, the TAND Checklist, modiﬁed based on feedback from
Stage 1, was administered to parents and caregivers of individuals with
TSC in Cape Town, South Africa. After completion of the TAND Checklist
with a research psychologist (L.L.), parents and caregivers were asked to
complete the Expert Feedback Form and were then asked to complete
four well-established and widely used rating scale measures: the
Strengths and Difﬁculties Questionnaire (SDQ),34 a widely used behav-
ioral screening questionnaire; the Social Communication Questionnaire
(SCQ),35 a secondary screening tool for autism spectrum disorder; the
Behaviour Rating Inventory of Executive Functions (BRIEF), developed to
quantify behavioral manifestations associated with executive func-
tioning in children, adolescents, and adults36; and the Wessex Scale,37 a
measure of adaptive behavior as proxy measure of intellectual disability
(ID).
Study participants
“Expert Professionals” were recruited in collaboration with the Tu-
berous Sclerosis Alliance to represent wide ranging areas of expertise
relevant to TSC. Snowball sampling was used where TSC expert pro-
fessionals were asked to recommend other TSC expert professionals for
participation until the desired number of responses (n ¼ 20) was
received. “Expert parents and caregivers” were recruited through two
mechanisms. The ﬁrst group consisted of parents, carers and individual
members of Australasian Tuberous Sclerosis Society. The second group
was representatives of Tuberous Sclerosis Complex International, a
global network of TSC parent, user and caregiver organizations. All Tu-
berous Sclerosis Complex International representatives were invited to
participate. Study participants for Stage 2 were recruited through the
Red Cross War Memorial Children’s Hospital TSC clinic in Cape Town,
TABLE 2.
Interpretation Table of Cronbach a Correlation Coefﬁcients
Cronbach a Internal consistency
a  0.9 Excellent (high stakes testing)
0.7  a < 0.9 Good (low stakes testing)
0.6  a < 0.7 Acceptable
0.5  a < 0.6 Poor
a < 0.5 Unacceptable
(Based on Kline, 1999)41
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TSC38,39 and had to have a parent or caregiver who could complete the
research questionnaires and interview in English. The research team
continued to recruit until 20 participants were identiﬁed. All participants
in this study were required to understand English and only an English
version of the TAND Checklist was used in Stages 1 and 2.
Research ethics
The study was conducted in compliance with the Declaration of
Helsinki. The protocol was peer reviewed in the Department of Psychi-
atry at the University of Cape Town and submitted for ethical approval at
the Faculty of Health Sciences, Human Research Ethics Committee
(Ethics Ref 200/2013). All participants received information about the
study and provided written informed consent. No young people
(<18 years) or individuals with intellectual disability directly partici-
pated in the study.
Data analysis
For the TAND Checklist, individual items were scored as simple yes or
no responses. Selected items were grouped together to form domains
and subdomains for the purpose of analysis along with the four external
assessment tools total and subscale scores. For pilot validation, we used
the Behavioral domain (Question 3, subdomains included “hyperactivi-
ty” and “social communication”), Intellectual ability domain (Question
5), the Academic domain (Question 6), Neuropsychologic domain
(Question 7, subdomain “executive skills”), Psychosocial domain (Ques-
tion 8), and the two Impact scores (Questions 9 and 12).
Standard scoring methods were used for the SDQ, SCQ, and BRIEF
tools. No standardized scoring procedures for the Wessex have been
published to date. For the purpose of this study, consensus judgment
scores of intellectual ability based on information provided in the Wes-
sex questionnaire were generated by two of the authors (L.L., P.J.d.V.),
blind to the TAND Checklist information.
Data were analyzed using IBM SPSS Statistics for Macintosh, Version
21.0 (IBM, Armonk, NY). Quantitative data analysis was performed using
nonparametric tests given the relatively small sample size. Item-by-item
analysis was examined by applying the Mann-Whitney test, and the chi-
square test was used for dichotomous variables. For interpretation of
Spearman r values generated by correlations, standard convention was
used (Table 1). Internal consistency of the TAND Checklist was examined
by applying Cronbach a coefﬁcient. Interpretation of Cronbach a values
generated by correlations is listed in Table 2.
Qualitative data were analyzed using summative content analysis,42
which consisted of counting and comparing keywords and concepts
followed by interpretation of the underlying constructs.
Results
Stage 1 resultsdexpert review of the TAND Checklist
Twenty expert feedback forms were returned by expert
professionals. Sixty-ﬁve percent (65% or 13 of 20)
completed the quantitative items, and 85% (17 of 20) pro-
vided both quantitative and qualitative feedback. All dataTABLE 1.
Interpretation Table of Spearman Rank-Order Correlation Coefﬁcients
Spearman r Correlation
0.70 Very strong relationship
0.40-0.69 Strong relationship
0.30-0.39 Moderate relationship
0.20-0.29 Weak relationship
0.01-0.19 No or negligible relationship
This descriptor applies to both positive and negative relationships.
(Adapted From Dancey and Reidy, 2004)40were used for analysis. Forty-two (42) parent or caregiver
expert feedback forms were returned. One hundred percent
completed the quantitative items, and 81% (34 of 42)
completed both quantitative and qualitative questions.
Stage 1 quantitative feedback
The Expert Feedback Form asked respondents to rate ﬁve
questions on a Likert scale from 0 to 5 with 5 as the highest
score and allowed for comments on each question. Given
the relatively small sample size, means, median, and stan-
dard deviations are presented (Table 3).
Feedback from expert professional participants showed
that the median score for Items 1 and 2 (“comprehensive-
ness” and “clarity”) were 5 out of amaximum 5 and Items 3-
5 (“ease of use,” “likelihood of clinician use,” “likelihood of
next step evaluation, treatment or referral”) were scored 4
of 5.
Expert parents and caregivers had a median score of 5 on
Items 1-3 relating to comprehensiveness, clarity, and ease
of use. Item 4 (“How likely do you think clinicians are to use
the Checklist?”) had amedian score of 3. Item 5 (“How likely
is the Checklist to encourage clinicians to pursue further
neuropsychiatric evaluation or referral to relevant special-
ists?”) had a median score of 4. Statistical comparison be-
tween expert professional and expert parent scores showed
no signiﬁcant differences (Table 3).
Stage 1 qualitative feedback
For qualitative analysis, all comments made by the
expert professionals and expert parents (n¼ 69) were used.
Summative analysis revealed six key themes (Fig 1). The
ﬁrst theme related to administration, such as where the
TAND Checklist should be administered and by whom. The
second theme that emerged centered around intellectual
ability. Respondents felt it was important to establish the
level of intellectual ability of a participant at the start of the
TAND Checklist as it may inﬂuence administration of the
remaining questions. Both expert professionals and expert
parents and caregivers suggested including examples that
would make it easier for parents to understand speciﬁc
technical or medical terms such as “visuo-spatial skills.”
There was a total of 22 comments on missing items where
experts suggested the inclusion of additional items. Nine
comments proposed that the TAND Checklist also be used
for other purposes such as research or training. The last
theme that emerged, overwhelmingly from the parent
group (13 comments), highlighted the need for parents to
drive clinical usage of the TAND Checklist. Feedback from
Stage 1 was used to revise the TAND Checklist, and the
revised TAND Checklist was used in Stage 2 of the study.
TABLE 3.
Stage 1 Quantitative Expert Feedback About the TAND Checklist
Item Expert Professional,
Mean (SD), N ¼ 13
Expert Professional,
Median
Expert Parent and Caregiver,
Mean (SD), N ¼ 42
Expert Parent and
Caregiver, Median
Mann-Whitney U* P Value*
Comprehensiveness 4.62 (0.87) 5 4.60 (0.80) 5 260 0.741
Clarity 4.31 (0.85) 4 4.48 (0.78) 5 229 0.466
Ease of use 4.31 (0.95) 5 4.56 (0.79) 5 214.5 0.332
Clinician usage 3.77 (0.83) 4 3.43 (1.04) 3 178.5 0.232
Subsequent referral 4.15 (0.69) 4 4.11 (0.84) 4 236.5 0.925
Abbreviations:
SD ¼ Standard deviation
TAND ¼ Tuberous sclerosis complex-associated neuropsychiatric disorders
Key to scores: 1 ¼ “not at all”;
5 ¼ “very much.”
* Statistical comparison between expert professional and expert parent scores.
L. Leclezio et al. / Pediatric Neurology 52 (2015) 16e24 19TAND Checklist internal consistency
The total number of behavioral items (Question 3) on the
TAND Checklist showed good internal consistency
(a ¼ 0.884). The hyperactivity subdomain items (Question
3n-3q) also generated a high Cronbach a (a ¼ 0.751), and
the social communication subdomain (Question 3h-3m)
showed an acceptable level of internal consistency
(a ¼ 0.682). The four components in the academic domain
(Question 6) showed excellent internal consistency
(a ¼ 0.954). Both the overall neuropsychologic domain
items (Question 7) and executive function subdomain items
(Question 7b-7e) showed good internal consistency (overall
a ¼ 0.783, executive subdomain a ¼ 0.792). Internal con-
sistency of the psychosocial domain (Question 8) was
relatively poor (a ¼ 0.365).
Stage 2 resultsdface-to-face administration of the TAND Checklist
and external validation
A total of 20 parents, caregivers, or individuals with TSC
were recruited for Stage 2. The mean age of our TSC popu-
lation of 20 patients was 14.25 years (range 3-42 years). The
gender ratio was 12:8 male to female.FIGURE 1.
Frequency distribution of qualitative responses from Expert groups across 6 thStage 2 quantitative feedback
The median scores assigned across the ﬁve questions
were 5 for Items 1, 2, and 5 and 4 for Items 3 and 4. Scores
on Items 1 and 3 ranged between 3 and 5, Item 2was scored
either 4 or 5, and Items 4 and 5 had a slightly broader range
between 2 and 5 (Table 4). To determine whether live
administration may have led to different perceptions of the
TAND Checklist, results from parents in Stage 2 was
compared with parents and carers in Stage 1. No statistical
differences were identiﬁed across four of the ﬁve items
between scores on Stage 2 live administration and Stage 1
expert parents and caregivers except Item 2 (clarity) that
was rated signiﬁcantly higher in the Stage 2 live adminis-
tration group (Mann-Whitney U ¼ 249, P ¼ 0.003; Table 5).
Stage 2 qualitative feedback
Nine qualitative comments were received from parents
during Stage 2. These included contemporaneously docu-
mented comments during administration. Comments
included possible missing items, but were mainly around
future concerns and psycho-educational questions about
TSC. Families reported the process of participation as very
positive and validating.emes. (The color version of this ﬁgure is available in the online edition.)
TABLE 4.
Stage 2 Quantitative Feedback About the TAND Checklist Following Face-to-Face
Administration With Stage 2 Participants
Item Median, N ¼ 20 Mean (SD)
Comprehensiveness 5 4.8 (0.52)
Clarity 5 4.95 (0.22)
Ease of use 4 4.45 (0.69)
Clinical usage 4 3.65 (0.14)
Subsequent referral 5 4.4 (0.88)
Abbreviations:
SD ¼ Standard deviation
TAND ¼ Tuberous sclerosis complex-associated neuropsychiatric
disorders
Key to scores: 1 ¼ “not at all”
5 ¼ “very much.”
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External validation aimed to compare domains and
subdomains of the TAND Checklist with relevant well-
validated external tools. Figure 2 illustrates the correlation
between the TAND Checklist behavioral domain total
score (Question 3a-3s) and the total difﬁculties score on the
SDQ.
Results reveal a strong positive correlation (r ¼ 0.81,
P < 0.001). To examine hyperactivity-related behaviors, the
TAND Checklist hyperactivity subdomain items (Question
3n-3q) were plotted against the hyperactivity or inattention
domain items of the SDQ. Results demonstrated a strong
correlation (r ¼ 0.77, P < 0.001). The TAND Checklist social
communication subdomain items or score (Question 3h-
3m) and the total scores on the SCQ show a strong linear
correlation (r ¼ 0.70, P ¼ 0.002). The SDQ prosocial domain
is a measure of positive or prosocial behaviors, predicted to
correlate inversely with social communication difﬁculties.
Results conﬁrmed a strong negative correlation (r ¼ 0.65,
P ¼ 0.002) between the prosocial domain of the SDQ and
the TAND social communication subdomain score. In
Question 5, parents were asked about intellectual disability
in their child or family member. Parental judgment of the
presence or absence of ID was compared with researcher
judgment based on theWessex questionnaire scores. Cross-
tabulation of ﬁndings is illustrated in Fig 3 (Fisher exact test,
P < 0.001). The two-by-two contingency table showed a
signiﬁcant association between the two classiﬁcations
(Fisher exact test, P < 0.001).
The neuropsychologic domain score (Question 7a-7f)
was plotted against the domain scores of the BRIEF. Results
revealed a strong positive correlation between with the
Global Executive Score (r ¼ 0.79, P < 0.001) and the BRIEF
Behavior Rating Index (BRI) score (r ¼ 0.74, P ¼ 0.001) andTABLE 5.
Comparison of Pen-and-Paper versus Live Administration of the TAND Checklist to
Expert Parents and Caregivers
Item Stage 1 vs Stage 2
Mann-Whitney U
P Value
Comprehensiveness 364 0.259
Clarity 249 0.003
Ease of use 341.5 0.362
Clinical usage 311.5 0.482
Subsequent referral 292.5 0.162
Abbreviation:
TAND ¼ Tuberous sclerosis associated neuropsychiatric disordersmoderate correlation with the BRIEF Metacognition Index
(MI; r ¼ 0.59, P ¼ 0.016). Given the fact that the TAND
Checklist neuropsychologic domain included a number of
executive skills (speciﬁcally measured in the BRIEF), it was
important to examine executive skills speciﬁcally. The
TAND Checklist executive skills subdomain scores (Question
7b-7e) showed strong correlation with the BRIEF Global
Executive Score (r ¼ 0.79, P < 0.001), the BRI score
(r ¼ 0.75, P ¼ 0.001), and the MI score (r ¼ 0.65, P ¼ 0.006).
The correlation between the TAND executive subdomain
and BRIEF BRI domain is shown in Fig 4.
No external tools of academic skills were included in this
study. However, we predicted that individuals with a lower
Wessex score, suggesting ID, would have higher rates of
academic difﬁculties reported in their TAND Checklist.
Eighty percent (16 of 20) of participants were of school
going age or above and could be examined for scholastic
difﬁculties. The TAND Checklist identiﬁed seven individuals
with academic difﬁculties of whom six were judged to have
ID as based on the Wessex Scale.
Administration of the TAND Checklist tookw10 minutes,
and the duration of Stage 2 data collection was between
45 minutes and 1.5 hours.How many participants had lifetime TAND difﬁculties reported?
The TSC literature summarized in the introduction pro-
vided rates of difﬁculties across groups of individuals, for
instance, to report that 40% of childrenwith TSC had anxiety
symptoms or that 57% had temper tantrums.15 However,
there were no data to indicate what proportion of in-
dividuals with TSC had one or more of these TAND behav-
ioral challenges as a marker of lifetime rates of TAND
difﬁculties. We therefore calculated the number of partici-
pants (of the total n ¼ 62) who had a lifetime report of one
or more TAND behavioral difﬁculties endorsed. One hun-
dred percent of participants had one or more lifetime re-
ported TAND behavioral difﬁculties, 97% had two or more
difﬁculties, 93% had four or more difﬁculties, and 89% had
six or more lifetime behavioral difﬁculties.Discussion
Results from this study demonstrated high scores across
the main areas of face and content validity examined. Ex-
perts from 28 countries participated in Stage 1 suggesting
that the TAND Checklist has broad and global face and
content validity. The many helpful suggestions from ex-
perts were incorporated into the revised version of the
TAND Checklist, such as addition of a developmental sec-
tion at the start of the TAND Checklist to provide an
overview of the functional ability level of the participant.
Results from Item 4 on the Expert Feedback Form (“clinical
usage”) indicated hesitation as to whether clinical teams
would use the TAND Checklist in practice. It is possible that
there may have been concern regarding the time re-
quirements to complete the tool in the context of a busy
clinic schedule or that experts did not feel that they would
have the necessary competence to complete the TAND
Checklist with families. It was therefore interesting to
observe a strong theme from expert parents about the
FIGURE 2.
Correlation between the TAND Checklist Total Behavior Score (maximum score ¼ 19) and the SDQ Total Difﬁculties Score (maximum score ¼ 40; Rho ¼
0.81; P < 0.001). (The color version of this ﬁgure is available in the online edition.)
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usage of the TAND Checklist.
No statistical differences were observed between re-
sponses of expert professionals and expert parents in Stage
1. It was therefore interesting to observe a statistically sig-
niﬁcant difference between Stage 1 expert parents or
caregivers and Stage 2 live administration participants
regarding clarity. Results suggest that face-to-face admin-
istration of the TAND Checklist led to increased clarity,
providing good support for the face-to-face approach when
using the TAND Checklist.
Examination of internal consistency suggested that the
TAND Checklist has acceptable-to-excellent internal con-
sistency within the domains and subdomains measured.FIGURE 3.
Cross-tabulation of the relationship between parental judgement of intel-
lectual ability and clinician rating based on the Wessex scale (Fisher’s Exact
P < 0.001).The items from the psychosocial domain did not appear to
have good internal consistency. On closer inspection, the
three elements of this item include intra- and interpersonal
factors (self-esteem, family stress, and parental relationship
stress), where high internal consistency may not be ex-
pected. We suggest that the psychosocial domain should
therefore be used simply as an introduction to a conversa-
tion about this important level of investigation.
One of the main objectives of the study was to investi-
gate external validity of the TAND Checklist domain and
subdomains. The behavioral domain items of the TAND
Checklist correlated very strongly with the total difﬁculties
score of the SDQ, suggesting that the TAND behavioral
question may be helpful at identifying a range of behavioral
difﬁculties that may underlie a range of psychopathologies
as screened for using the SDQ. Results within the sub-
domain of hyperactivity also showed strong correlation
between items associated with hyperactivity in the TAND
Checklist and the total hyperactivity or inattention score
produced by the SDQ assessment tool, suggesting that
endorsement of the hyperactivity items on the TAND
Checklist should raise the clinical suspicion of ADHD or an
attention-related disorder. The TAND Checklist social
communication subdomain constructs correlated strongly
with items from the SCQ, highlighting behaviors associated
with ASDs. Findings suggested that these itemsmay be very
useful markers of risk for ASD, which is known to have a
very high prevalence in TSC. Overall, results from the
behavioral domain suggested that ADHD- and ASD-related
behaviors, two key developmental challenges in TSC, may
usefully be identiﬁed through the TAND Checklist.
There was a moderate correlation between the level of
intellectual ability as perceived by parents and researcher
judgment based on the Wessex scale. Results suggest that
parental perception of intellectual development is generally
FIGURE 4.
Correlation between the TAND Executive Function Score and BRIEF Behaviour Rating Index (Rho ¼ 0.75; P ¼ 0.001). (The color version of this ﬁgure is
available in the online edition.)
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intelligence, all individuals with TSC are recommended to
have a formal assessment of their intellectual strengths and
weaknesses at key developmental time points.9
At the neuropsychologic level, the TAND Checklist
showed very strong correlation with the BRIEF. There were
strong correlations when comparing the total TAND neu-
ropsychologic score with the global executive score and BRI
of the BRIEF, suggesting that the TAND Checklist may be
useful to highlight broad overall neuropsychologic concerns
and behavior-related difﬁculties such as inhibition, shifting
between tasks, or emotional control. The moderate corre-
lation observed between the TAND total score and the MI of
the BRIEF suggested that the TAND Checklist did not fully
capture the ﬁner constructs identiﬁed by the MI including
initiation, working memory, planning or organizing, and
monitoring skills. It was very encouraging that the TAND
Checklist executive function subdomain correlated strongly
with all three subscales of the BRIEF. Taken together, results
suggest that the TAND Checklist may be very helpful in
identifying individuals at risk of potential neuropsychologic
and, in particular, executive difﬁculties that would beneﬁt
from further evaluation and intervention.
The striking ﬁnding that almost 90% of participants in the
study had six or more lifetime TAND behavioral difﬁculties
underlined why TAND is such a crucial clinical domain to
consider in real life. Further investigations of the lifetime
rates across TAND levels of investigation may provide
extremely helpful information.
Limitations of the study
In spite of the positive initial ﬁndings of this pilot study,
it is important to consider potential limitations. This study
did not examine reliability of the TAND Checklist such asinter-rater or test-retest reliability. It might be very helpful
to examine inter-rater reliability, in particular, to see if
relatively nonexpert clinicians will get similar scores to
very experienced TSC clinicians. We predict that the
quality of information collected through the TAND
Checklist will most strongly depend on the quality of the
rapport between the interviewer and interviewee. Test-
retest reliability is often examined for questionnaires. It
is not clear how useful this would be for a TAND Checklist
given that new neuropsychiatric manifestations may pre-
sent over the course of a few weeks to months, thus
reducing the likelihood of high stability of measurement. It
was outside the scope of this study to examine sensitivity
and speciﬁcity of the tool. As raised in the introduction, the
purpose of the TAND Checklist was not to generate a
“diagnostic tool” with thresholds or “cut-off values” for
disorders (see also details of the conceptualization of
TAND and the TAND Checklist32). For this reason, sensi-
tivity and speciﬁcity were not the key considerations in
this pilot validation. Further evaluation of other psycho-
metric properties of the TAND Checklist may be natural
next steps.
Future directions
Further research is required to replicate and extend
investigation of the psychometric properties of the TAND
Checklist. Further subsequent validity research studies will
help to ascertain whether annual screening of TAND will
address the treatment gap of neuropsychiatric disorders.
Families and clinicians may also beneﬁt from a tool kit
containing “next step, self-help” information and access to
resources, especially in low- and middle-income countries
and other low resource environments where access to
highly specialized clinicians and TSC centers is limited.
L. Leclezio et al. / Pediatric Neurology 52 (2015) 16e24 23We deliberately chose to perform pilot validation in
South Africa, a middle-income country, where we expected
baseline knowledge not to be very high, and where levels of
academic and socioeconomic status and competence in
English would be quite variable. We argued that the tool
needed to be such that it would be easily accessible to in-
dividuals from low- and middle countries. It was therefore
very encouraging to observe that one simple tool that takes
approximately 10 minutes to complete captured informa-
tion relevant to TSC in a way that correlated very well with
four external tools.Conclusion
In this research project, we performed the ﬁrst evalua-
tion of the TAND Checklist, a newly developed, freely
available tool to screen for TAND. Results suggested that
overall the TAND Checklist was deemed to be a good tool to
identify possible neuropsychiatric difﬁculties. Qualitative
feedback provided information for minor improvements to
the TAND Checklist and raised the importance of families
leading the use of the TAND Checklist in partnership with
their health-care teams. We suggest that the TAND Check-
list may be a helpful tool for annual screening of TAND, as
recommended at the 2012 International Consensus
Conference.9
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